MV Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483 | Sell |
2
-16
| -89% | -$3.86K | ﹤0.01% | 852 |
|
|
2025
Q1 | $4.39K | Buy |
18
+4
| +29% | +$974 | ﹤0.01% | 631 |
|
|
2024
Q4 | $4.6K | Hold |
14
| – | – | ﹤0.01% | 616 |
|
|
2024
Q3 | $4.69K | Buy |
14
+3
| +27% | +$1K | ﹤0.01% | 634 |
|
|
2024
Q2 | $3.01K | Sell |
11
-17
| -61% | -$4.64K | ﹤0.01% | 635 |
|
|
2024
Q1 | $9.69K | Sell |
28
-2
| -7% | -$692 | ﹤0.01% | 527 |
|
|
2023
Q4 | $9.69K | Buy |
30
+9
| +43% | +$2.91K | ﹤0.01% | 524 |
|
|
2023
Q3 | $7.53K | Sell |
21
-6
| -22% | -$2.15K | ﹤0.01% | 544 |
|
|
2023
Q2 | $10.2K | Buy |
27
+7
| +35% | +$2.65K | ﹤0.01% | 507 |
|
|
2023
Q1 | $9.58K | Buy |
20
+1
| +5% | +$479 | ﹤0.01% | 517 |
|
|
2022
Q4 | $7.99K | Buy |
19
+12
| +171% | +$5.05K | ﹤0.01% | 495 |
|
|
2022
Q3 | $3K | Buy |
7
+1
| +17% | +$429 | ﹤0.01% | 581 |
|
|
2022
Q2 | $3K | Sell |
6
-1
| -14% | -$500 | ﹤0.01% | 594 |
|
|
2022
Q1 | $4K | Sell |
7
-2
| -22% | -$1.14K | ﹤0.01% | 605 |
|
|
2021
Q4 | $7K | Buy |
9
+6
| +200% | +$4.67K | ﹤0.01% | 522 |
|
|
2021
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 664 |
|
|
2021
Q2 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 614 |
|